Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.40 Consensus Price Target from Brokerages
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The […]
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The […]
